{"id":47670,"date":"2022-08-25T16:02:19","date_gmt":"2022-08-25T14:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/"},"modified":"2022-08-25T16:02:19","modified_gmt":"2022-08-25T14:02:19","slug":"ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/","title":{"rendered":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree"},"content":{"rendered":"
\n

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth<\/a>,<\/span> a global healthcare and specialty pharmacy solutions company, has been named a 2022 Philadelphia (PHL) Inno Fire Award<\/a> honoree in the Ablaze category for tech-enabled growth and service in the health care industry. The annual awards recognize 20 organizations and individuals who are setting the innovation scene on fire in the Greater Philadelphia market.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cThis recognition is a tribute to our staff who dedicate their energy, passion and expertise to helping people with rare diseases and complex medical conditions and other industry stakeholders via our innovative programs and services for enhanced medication access and clinical outcomes,\u201d says Dea Belazi, president and CEO, AscellaHealth. \u201cIt humbles us to be recognized by the Philadelphia business community for our work benefiting patients, payers, pharmaceutical manufacturers and providers.\u201d\n<\/p>\n

\nAscellaHealth has applied a clinical, technology-based service delivery model to access specialty medications, increase clinical outcomes and improve the patient experience. Its customized, a la carte menu program and services to improve access to expensive, specialty pharmaceuticals set the trends for industry.\n<\/p>\n

\n\u201cOur amazing and dedicated teams deserve the credit for the unprecedented growth of AscellaHealth,\u201d adds Belazi. \u201cThis honor is further testimony to their accomplishments.\u201d\n<\/p>\n

\nDuring the evaluation period for the 2022 Fire Award, AscellaHealth acquired Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization. Optime Care offers a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders.\n<\/p>\n

\n\u201cThis acquisition has not only rounded out AscellaHealth\u2019s suite of services to support all segments of the industry, including patients, payers, pharmaceutical manufacturers and providers but also contributed to significant staff expansion and year-over-year revenue growth,\u201d concludes Belazi.\n<\/p>\n

\nAbout AscellaHealth LLC<\/b>\n<\/p>\n

\nAscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences manufacturers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner, AscellaHealth\u2019s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and\/or gene and cell therapies. Most recently, AscellaHealth has joined with its subsidiaries, Optime Care<\/a> and Terebellum<\/a> to form the AscellaHealth Family of Companies. Visit www.AscellaHealth.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Nicole Dufour
\n
CPR Communications
\n
ndufour@cpronline.com<\/a>
201.641.1911 x 54\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy solutions company, has been named a 2022 Philadelphia (PHL) Inno Fire Award honoree in the Ablaze category for tech-enabled growth and service in the health care industry. The annual awards recognize 20 organizations and individuals who are setting the innovation scene on fire in the Greater … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47670","6":"format-standard","7":"category-industry"},"yoast_head":"\nAscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy solutions company, has been named a 2022 Philadelphia (PHL) Inno Fire Award honoree in the Ablaze category for tech-enabled growth and service in the health care industry. The annual awards recognize 20 organizations and individuals who are setting the innovation scene on fire in the Greater ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-25T14:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree\",\"datePublished\":\"2022-08-25T14:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/\"},\"wordCount\":401,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005042\\\/en\\\/1551838\\\/21\\\/The_Fire_Awards.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/\",\"name\":\"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005042\\\/en\\\/1551838\\\/21\\\/The_Fire_Awards.jpg\",\"datePublished\":\"2022-08-25T14:02:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005042\\\/en\\\/1551838\\\/21\\\/The_Fire_Awards.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005042\\\/en\\\/1551838\\\/21\\\/The_Fire_Awards.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/","og_locale":"en_US","og_type":"article","og_title":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend","og_description":"BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy solutions company, has been named a 2022 Philadelphia (PHL) Inno Fire Award honoree in the Ablaze category for tech-enabled growth and service in the health care industry. The annual awards recognize 20 organizations and individuals who are setting the innovation scene on fire in the Greater ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-25T14:02:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree","datePublished":"2022-08-25T14:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/"},"wordCount":401,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/","url":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/","name":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg","datePublished":"2022-08-25T14:02:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220825005042\/en\/1551838\/21\/The_Fire_Awards.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-named-philadelphia-business-journal-phl-inno-2022-fire-award-honoree\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AscellaHealth Named Philadelphia Business Journal PHL Inno 2022 Fire Award Honoree"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47670"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47670\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}